Key result
Suboptimal post-PCI FFR (<0.90) was not associated with major adverse cardiac events at 2 years (HR 1.08; 95% CI 0.73-1.60; P=0.707).
Why the study?
FFR-guided treatment improves PCI results, but little is known about the long-term impact of low post-PCI FFR.
Does suboptimal post-PCI FFR (<0.90) increase the risk of major adverse cardiac events in patients undergoing successful PCI?
Cohort (n=1,000)
Does suboptimal post-PCI FFR (<0.90) increase the risk of major adverse cardiac events in patients undergoing successful PCI?
Hazard Ratio: 1.08 (95% CI 0.73–1.6)
p-value: p=0.707
Suboptimal post-PCI FFR (<0.90) does not significantly increase overall MACE but is associated with a higher rate of target vessel revascularization at 2 years.
Suboptimal post-PCI FFR should not alter management to reduce MACE; leaves open its link to target vessel revascularization.
Background: Fractional flow reserve (FFR)-guided treatment has been demonstrated to improve percutaneous coronary intervention (PCI) results. However, little is known on the long-term impact of low post-PCI FFR. Methods: This is a large prospective all comers study evaluating the impact of post-PCI FFR on clinical outcomes. All patients undergoing successful PCI were eligible for enrollment. FFR measurements were performed immediately after PCI when the operator considered the angiographic result acceptable and final. No further action was undertaken based on the post-PCI result. Suboptimal post-PCI FFR was defined as FFR<0.90. The primary end point was major adverse cardiac events, a composite of cardiac death, any myocardial infarction, or any revascularization at 2-year follow-up. Secondary end points were target vessel revascularizations and stent thrombosis and the separate components of the primary end point. Results: A total of 1000 patients were enrolled. Post-PCI FFR was successfully measured in 1165 vessels from 959 patients. A poststenting FFR<0.90 was observed in 440 vessels (37.8%). A total of 399 patients had at least 1 vessel with FFR<0.90 post-PCI. At 2-year follow-up, a patient level analysis showed no association between post-PCI FFR and major adverse cardiac event (hazard ratio [HR], 1.08 [95% CI, 0.73–1.60], P =0.707), cardiac death (HR, 1.55 [95% CI, 0.72–3.36], P =0.261), any myocardial infarction (HR, 1.53 [95% CI, 0.78–3.02], P =0.217). A vessel level analysis showed a higher rate of target vessel revascularization (HR, 1.91 [95% CI, 1.06–3.44], P =0.030) and a tendency toward higher rate of stent thrombosis (HR, 2.89 [95% CI, 0.88–9.48], P =0.081) with final post-PCI FFR<0.90. Conclusions: Suboptimal post-PCI FFR has only a moderate impact on major adverse cardiac event but coronary arteries with a post-PCI FFR<0.90 have a higher rate of target vessel revascularization.
No takes yet. Share an insight, caveat, or question.
Diletti et al. (2021) conducted a cohort in Patients undergoing successful percutaneous coronary intervention (n=1,000). Suboptimal post-PCI FFR (<0.90) vs. Optimal post-PCI FFR (≥0.90) was evaluated on Major adverse cardiac events, a composite of cardiac death, any myocardial infarction, or any revascularization (HR 1.08, 95% CI 0.73-1.60, p=0.707). Suboptimal post-PCI FFR (<0.90) was not associated with major adverse cardiac events at 2 years (HR 1.08; 95% CI 0.73-1.60; P=0.707).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: